Month: June 2020

SAN FRANCISCO, June 08, 2020 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE:DLB) today announced that Kevin Yeaman, President and CEO, Dolby Laboratories, will present at the William Blair 40th Annual Growth Stock Conference to be held virtually on Wednesday, June 10, 2020, at 10:40 a.m. CDT.A live webcast and replay of the presentation will be available at http://investor.dolby.com.About Dolby LaboratoriesDolby Laboratories (NYSE: DLB) is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research and engineering, we create breakthrough experiences for billions of people worldwide through a collaborative ecosystem spanning artists, businesses, and consumers. The experiences people have – with Dolby Cinema,...

LEXINGTON, Mass., June 08, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that in light of the COVID-19 pandemic, its 2020 Annual Meeting of Stockholders will now be held solely by live webcast to comply with public health recommendations and protect the health of employees, Stockholders and directors. Stockholders will no longer be able to attend the Annual Meeting in person.As previously announced, the meeting will be held on Wednesday, June 17, 2020, at 9:00 a.m. Eastern Daylight Time (EDT). There are no changes to the items of business to be addressed at the Annual Meeting, which are described in Kaleido’s proxy materials that were distributed previously...

VANCOUVER, British Columbia, June 08, 2020 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) announces that partner company Azincourt Energy Corp. (“Azincourt”) has released results from its winter 2020 phase two drill program at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada. A summer/fall 2020 work program is already being planned to follow up on the drill program.Preston Uranium Project Claims Map:http://skyharbourltd.com/_resources/maps/SYH_Patterson_Lake_Area_Promo_20161212_blue_hi_res.pdfSkyharbour and Dixie Gold Inc. (“Dixie Gold”) entered into an Option Agreement (the “Agreement”) with Azincourt whereby Azincourt has an earn-in option to acquire a 70% working interest in a portion of the Preston Uranium Project known...

VANCOUVER, Colombie-Britannique, 08 juin 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTCQB : SHRMF), une société des sciences de l’optimisation humaine mettant l’accent sur la kétamine et la médecine psychédélique, a le plaisir d’annoncer qu’elle a choisi la société torontoise Dalriada Drug Discovery Inc. (« Dalriada ») afin de faire progresser son nouveau portefeuille de PI pour les entités chimiques (« PEC ») en ce qui concerne la kétamine et les échafaudages moléculaires de psilocybine/psilicineDalriada, une importante organisation de recherche contractuelle (ORC) dans le domaine de la découverte de médicaments, dirigera les nouveaux programmes de recherche de médicaments de Champignon dans l’espace des PEC et fournira en outre un soutien en R et D intégré pour faire...

CHARLESTON, S.C., June 08, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that it has regained compliance with the minimum bid price for continued listing on the Nasdaq Capital Market, as the closing bid price of the Company’s common stock has been at $1.00 or greater for 10 consecutive trading days.On April 8, 2020, the Company received notice that its common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by Nasdaq. Now that the Company has regained compliance with this listing rule, Nasdaq has advised the Company that this matter is now closed.About Aeterna Zentaris Inc.Aeterna Zentaris Inc. is a specialty...

Shenzhen, China, June 08, 2020 (GLOBE NEWSWIRE) — ATIF Holdings Limited (NASDAQ: ATIF), a company providing business consulting services and multimedia services in Asia, today announced that the Company, through Qianhai Asia Time (Shenzhen) International Financial Services Co., Ltd. (“ATIF Shenzhen”), the Company’s variable interest entity in China, entered into a consulting service agreement, dated June 3, 2020 (the “Agreement”), to act as a business advisor for Shenzhen Agrecoe Biotechnology Co., Ltd. (“Agrecoe”), an emerging growth biotechnology company specializing in the research, development, production and sales of microbial inoculants in the three major fields of agriculture, environmental protection and food. The Agreement was signed in anticipation of Agrecoe’s entrance into the U.S. capital market.Pursuant to the Agreement,...

Lenexa, KS, June 08, 2020 (GLOBE NEWSWIRE) — Digital Ally, Inc. (DGLY) (the “Company”), which develops, manufactures and markets advanced video recording products for law enforcement, emergency management, fleet safety and security, today announced the pricing of an underwritten public offering of 2,325,581 shares of its common stock at a price of $2.15 per share, for gross proceeds to the Company of approximately $5 million, before deducting underwriting discounts and other offering expenses. The Company intends to use the net proceeds from this offering for working capital, product development, order fulfillment and for general corporate purposes. The Company priced the offering based on the last closing price.In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 213,953 shares of...

COPENHAGEN, Denmark, June 08, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced presentations related to its rare disease endocrinology programs at ENDO Online 2020, the annual meeting of the Endocine Society, taking place June 8 – 22, 2020.“The fliGHt Trial data presented at ENDO Online demonstrate that subjects taking daily somatropin can safely switch to TransCon hGH, our investigational long-acting prodrug that releases somatropin, with consistent and predictable efficacy,” said Jan Mikkelsen, Ascendis Pharma’s President and CEO. “Further, the interim data from heiGHt Trial subjects who continued in the enliGHten long-term extension trial demonstrated the maintenance of a height advantage...

BOCA RATON, Fla., June 08, 2020 (GLOBE NEWSWIRE) — ADT (NYSE: ADT) announced today that, via ADT Commercial, its commercial channel, it is joining forces with Dollar Tree, Inc. (NASDAQ: DLTR), to help provide protection to its retail locations nationwide. ADT Commercial, a premier provider of commercial security, fire, life safety and risk consulting services in the U.S., will provide comprehensive and innovative security solutions and monitoring services at the majority of Dollar Tree and Family Dollar locations across the U.S.“In these rapidly evolving times, we’re thrilled to be partnering with Dollar Tree for what marks the largest contract to-date for ADT Commercial,” said Jim DeVries, President and CEO of ADT. “Dollar Tree has shown itself to be a true industry leader by seeking out some of the most groundbreaking, enterprise-level...

CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it will host a conference call and webcast to discuss new clinical efficacy and safety data from the company’s ongoing Phase 2 open-label extension trial of its lead candidate, mavorixafor, in patients with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. The data will be presented in an e-poster (Abstract #EP852) at the 25th European Hematology Association (EHA) Annual Congress (“Congress”), taking place virtually from June 11-14, 2020.The X4 Pharmaceuticals conference call and webcast will take place at 8:30 am ET on June 12, 2020. The conference call can be accessed...